Waters Corporation WAT
433.54
3.24
0.75%
as of 25 Sep
- Market cap
- $42.3B
- P/E
- 108×
Follow WAT
Indexes
indicate stock being part of an index,
Insider Buys
alert about insiders buying in the last 12 month
Waters Corporation (WAT) Debt to equity
Waters Corporation's debt to equity at the end of the quarter to 30 June 2026 was 0.3×, down 0.0× from fiscal 2025 (0.4×). Over the past ten years it has ranged from −7.3× (fiscal 2019) to 5.2× (fiscal 2020); the current reading is higher than 18% of that period. That is above the Diagnostics & Research industry median of 0.1× and above the Healthcare sector median of 0.0×.
Debt to equity, annual
Annual
| Period | Debt to equity | Change |
|---|---|---|
| FY2025 | 0.4× | (58.41%) |
| FY2024 | 0.9× | (55.62%) |
| FY2023 | 2.0× | (33.69%) |
| FY2022 | 3.0× | (26.61%) |
| FY2021 | 4.1× | (20.75%) |
| FY2020 | 5.2× | — |
| FY2019 | −7.3× | — |
| FY2018 | 0.7× | (13.76%) |
| FY2017 | 0.8× | 14.89% |
| FY2016 | 0.7× | 1.96% |
Quarterly
| Period | Debt to equity | Change |
|---|---|---|
| Jun 2026 | 0.3× | 1.29% |
| Mar 2026 | 0.3× | (14.10%) |
| Dec 2025 | 0.4× | (9.06%) |
| Sep 2025 | 0.4× | (26.67%) |
| 42 more quarters | Free account |
Against its own ten years
Low −7.3×
High 5.2×
Ten-year median
0.8×
Current reading's percentile
18
Debt to equity against peers
| Company | Debt to equity |
|---|---|
| GH Guardant Health, Inc. compare | −6.7× |
| NTRA Natera, Inc. compare | 0.0× |
| IDXX IDEXX Laboratories, Inc. compare | 0.3× |
| WAT Waters Corporation | 0.3× |
| A Agilent Technologies, Inc. compare | 0.5× |
| ILMN Illumina, Inc. compare | 0.5× |
| DGX Quest Diagnostics Incorporated compare | 0.7× |
| IQV IQVIA Holdings Inc. compare | 2.5× |
| MTD Mettler-Toledo International, Inc. compare | 165× |
| Diagnostics & Research industry median | 0.1× |
| Healthcare sector median | 0.0× |
| Market median | 0.2× |
What Debt to equity is
Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.
(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)
More on WAT
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement